Charles River to Supply Pfizer's Genetically Modified Research Models
March 3, 2011 - Charles River has entered into a marketing and distribution agreement with Pfizer, Inc., to provide certain Pfizer-developed genetically modified research models to the global biomedical research community. The Pfizer strains encompass several different therapeutic areas, including CNS, diabetes, inflammation and cardiovascular disease. The table below contains general details on each strain. Additional information can be accessed by clicking on each strain line’s name or the corresponding publication link (if available).
The ordering process is simple and straightforward, and our team of animal specialists can work with you to make all the necessary shipping arrangements and answer any questions you may have. As an industry leader in colony development and animal production services, we are pleased to feature these valuable Pfizer strains in our growing portfolio of research models and animal support services.
For more information or to receive a quote, please contact us at 1.877.CRIVER.1 (1.877.274.8371) or firstname.lastname@example.org.
Note: These models may be subject to the licensed patents and are sold only for research purposes under agreement from Pfizer, Inc.
For more information, contact us at:
*indicates a required field.
The information you provided will be kept confidential.
Clinical pathology data can assist you in selecting the most appropriate model for your study and can provide important information on the physiology and health of your research animals.
We are now the exclusive distributor of the TARGATT™ mouse. The TARGATT mouse is a transgenic mouse designed to produce animal models with investigator designed exogenous DNA sequences knocked-in to a specific site.
Jun 10–Jun 13
Visit us in booth #091 to learn more about our recent innovations including expanded diagnostic capabilities, a new online portal connecting clients with their colonies and a deep-rooted commitment to humane care.
May 21–May 24
RDD Europe 2013 is a forum for pulmonary and nasal drug delivery experts from all around the world to exchange scientific knowledge and expertise.
May 23–May 23
This full-day seminar encompasses selected topics from our Charles River Short Course on Laboratory Animal Science. We would like to acknowledge Michigan State University for hosting this event and extend our heartfelt thanks to guest speaker Dr. Danielle Ferguson.
This position is responsible for serving as a as a study director (SD), project scientist (PS) and/or principal investigator (PI) in the direction and execution of assigned studies in compliance with GLP regulations as they apply to the conduct of nonclinical research; coordinating all phases of the study planning process with appropriate departments; generating high-quality project plans, protocols, amendments and reports appropriate for assigned studies; reviewing, interpreting, integrating and presenting data on assigned studies; and functioning as contact for the planning and execution of sponsor interaction related to assigned studies, including proposal management and study scheduling, conduct and reporting.
This position is responsible for managing international aspects of US Federal income tax compliance; assisting with international tax planning, including identification of planning opportunities, designing and implementing plans, and transfer pricing process; overseeing quarterly ETR forecast process; and participating in the tax provision process, including assessment of tax risks, documentation of key positions, and review of non-US tax provision submissions.
Charles River Laboratories, Inc.